Replies to post #3286 on Theriva Biologics Inc (TOVX)

[akasidney86]

I'm a relatively new (3 mo) holder, but it seems to me that the most likely pertinent data is as Pistol supposes... that the 24 month p value is over .05. That being said, it seems to me that the way forwards with the FDA will still not require a large P III, and a filing could be made based strictly upon the stat sig 12 month data, known MOA, clean safety profile, and known profile of copaxone. A nearly 50% improvement over SOC is nothing to ignore IMO.